Your session is about to expire
← Back to Search
Catheter ablation for Atrial Fibrillation (PLEA Trial)
PLEA Trial Summary
This trial is comparing the safety and effectiveness of four different treatments for atrial fibrillation.
PLEA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPLEA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PLEA Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the main goals of this research endeavor?
"According the trial sponsor, Biosense Webster, Inc., the primary outcome to be measured over a 12 month period is freedom from documented atrial fibrillation/atrial tachycardia episodes and all-cause mortality following initial procedure. Secondary outcomes include incidence of peri-procedural and post procedural complications such as stroke, pulmonary veins stenosis, cardiac perforation, esophageal injury etc; in addition to assessment of myocardial strain for evaluation of atrial contractility after catheter ablation."
Are there any unfilled openings for volunteers in this experiment?
"According to clinicaltrials.gov, this trial is actively searching for participants. The research initiative was launched on the 16th of January 2020 and recently revised on the 2nd August 2022."
What are the current venues for this trial?
"At this time, 10 sites across the country are taking on participants for this clinical trial. For example, there are centres in Bloomington, Larkspur and Austin among others. It is suggested that patients pick a location as near to them as possible to minimize travel requirements should they choose to take part."
Am I eligible to be included in this clinical investigation?
"This research project is seeking 932 individuals with atrial fibrillation who are within the age range of 18 to 99. Qualified participants will be able to take part in this medical trial."
How many individuals have opted to participate in this trial?
"To launch this trial, the sponsor Biosense Webster, Inc. will require a cohort of 932 qualified participants. The study's locations include Indiana University in Bloomington and MarinHealth Medical Center situated in Larkspur, California."
Does this research protocol permit seniors to participate?
"According to the eligibility criteria, potential participants must fall between 18 and 99 years of age. Additionally, 11 studies have been conducted with minors while 473 trials focus on patients over 65."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger